학술논문

A dendritic cell targeting NY-ESO-1 vaccine significantly augments early and durable immune responses in melanoma patients pretreated with human Flt-3 Ligand
Document Type
Journal
Source
JOURNAL FOR IMMUNOTHERAPY OF CANCER; NOV 7 2017, 5 2p. Supplement: 2
Subject
Language
English
ISSN
20511426